Margaret M. Dunne

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 427 citations · Full text

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

Peter J. Embí, Matthew E. Levy, Allison L. Naleway et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 188 citations · Full text

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

Ruth Link‐Gelles, Matthew E. Levy, Manjusha Gaglani et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 124 citations · Full text

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 109 citations · Full text

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 96 citations · Full text

Immunodeficiencies, Immunology, Advisory Committee +21